AtriCure receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AtriCure Inc (ATRC)
AtriCure Inc stock price live, this page displays NASDAQ ATRC stock exchange data. View the ATRC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the AtriCure Inc real time stock price chart below.
What Is the AtriCure Inc Stock Price Today?
The AtriCure Inc stock price today is 31.26.
What Is the Stock Symbol for AtriCure Inc?
The stock symbol for AtriCure Inc is "ATRC."
What Stock Exchange Does AtriCure Inc Trade On?
AtriCure Inc is listed and trades on the NASDAQ stock exchange.
Is AtriCure Inc a Good Stock to Buy?
Determining whether AtriCure Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATRC quote. (ISIN: US04963C2098)
What Is the AtriCure Inc Stock Price Today?
The AtriCure Inc stock price today is 31.26.
What Is the Stock Symbol for AtriCure Inc?
The stock symbol for AtriCure Inc is "ATRC."
What Stock Exchange Does AtriCure Inc Trade On?
AtriCure Inc is listed and trades on the NASDAQ stock exchange.
Is AtriCure Inc a Good Stock to Buy?
Determining whether AtriCure Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATRC quote. (ISIN: US04963C2098)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.66
31.31
52 wk Range
28.29
43.18
ATRC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.6631.31
52 wk Range
28.2943.18
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATRC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
49.38
Upside
+57.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
AtriCure Inc Company Profile
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula’s to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
AtriCure Inc Earnings Call Summary for Q2/2025
- AtriCure beats Q2 2025 EPS forecast with -$0.13 vs -$0.17 expected; revenue rises to $136.1M, surpassing $130.17M forecast
- Stock rises 2.35% in aftermarket trading; company maintains strong liquidity with current ratio of 4.11
- Revenue grows 17.1% YoY; strong performance in product innovation and clinical trials, despite 14.5% rise in operating expenses
- 2025 revenue guidance set at $527M-$533M, projecting 13-15% growth; Q3 expected to see modest sequential decline due to seasonality
- CEO highlights broad-based growth and commitment to innovation; company focuses on international expansion and product launches
Last Updated: 2025-07-29, 05:44 p/m
Read Full TranscriptCompare ATRC to Peers and Sector
Metrics to compare | ATRC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATRCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −136.0x | 5.0x | −0.6x | |
PEG Ratio | −1.82 | 0.36 | 0.00 | |
Price/Book | 3.2x | 3.1x | 2.6x | |
Price / LTM Sales | 2.9x | 2.9x | 3.3x | |
Upside (Analyst Target) | 63.1% | 33.6% | 44.9% | |
Fair Value Upside | Unlock | 15.5% | 5.6% | Unlock |
Analyst Ratings
7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 49.38
(+57.95% Upside)
Earnings
Latest Release
Feb 17, 2026
EPS / Forecast
0.06 / -0.10
Revenue / Forecast
140.50M / 139.55M
People Also Watch
FAQ
What Is the AtriCure (ATRC) Stock Price Today?
The AtriCure stock price today is 31.26 USD.
What Stock Exchange Does AtriCure Trade On?
AtriCure is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for AtriCure?
The stock symbol for AtriCure is "ATRC."
What Is the AtriCure Market Cap?
As of today, AtriCure market cap is 1.56B USD.
What Is AtriCure's Earnings Per Share (TTM)?
The AtriCure EPS (TTM) is -0.24.
When Is the Next AtriCure Earnings Date?
AtriCure will release its next earnings report on May 05, 2026.
From a Technical Analysis Perspective, Is ATRC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has AtriCure Stock Split?
AtriCure has split 0 times.
How Many Employees Does AtriCure Have?
AtriCure has 1350 employees.
What is the current trading status of AtriCure (ATRC)?
As of Mar 01, 2026, AtriCure (ATRC) is trading at a price of 31.26 USD, with a previous close of 31.64 USD. The stock has fluctuated within a day range of 30.66 USD to 31.31 USD, while its 52-week range spans from 28.29 USD to 43.18 USD.
What Is AtriCure (ATRC) Price Target According to Analysts?
The average 12-month price target for AtriCure is 49.38 USD, with a high estimate of 55 USD and a low estimate of 36 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +57.95% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.